Glaukos (GKOS) Cost of Revenue (2014 - 2026)
Glaukos (GKOS) posted quarterly Cost of Revenue of $34.0 million for Q2 2026, up 26.47% year-over-year from $26.9 million in Q2 2025, and up 2.03% quarter-over-quarter from $33.3 million in Q1 2026.
Glaukos (GKOS) Cost of Revenue (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has reported Cost of Revenue for 13 consecutive years, with $34.0 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Cost of Revenue rose 26.47% year-over-year to $34.0 million; the TTM figure through Jun 2026 stood at $128.0 million (up 24.92% YoY), while the FY2025 annual figure was $111.8 million, up 18.92% from the prior year.
- Cost of Revenue improved to $34.0 million in Q2 2026 per GKOS's latest filing, from $33.3 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $34.0 million in Q2 2026 and bottomed at $16.9 million in Q3 2022.
- Historically, Cost of Revenue has averaged $23.2 million across 5 years, with a median of $21.4 million in 2024.
- Annual changes were most pronounced in 2022 — Cost of Revenue climbed 0.42% — and 2024, when it soared 51.58%.
- Glaukos' Cost of Revenue stood at $17.2 million in 2022, then increased by 9.69% to $18.9 million in 2023, then surged by 51.58% to $28.6 million in 2024, then grew by 10.95% to $31.8 million in 2025, then rose by 7.07% to $34.0 million in 2026.
- Business Quant data shows GKOS's Cost of Revenue at $34.0 million in Q2 2026, $33.3 million in Q1 2026, and $31.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 808.60 Mn |
| 10 | Glaukos | 11.19 Bn | 11.08 Bn | 151.59 Mn | 34.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.02 Mn |
| Jun 30, 2026 | 34.02 Mn |
| Mar 31, 2026 | 33.34 Mn |
| Mar 31, 2026 | 33.34 Mn |
| Dec 31, 2025 | 31.77 Mn |
| Dec 31, 2025 | 31.77 Mn |
| Sep 30, 2025 | 28.83 Mn |
| Sep 30, 2025 | 28.83 Mn |
| Jun 30, 2025 | 26.90 Mn |
| Jun 30, 2025 | 26.90 Mn |
| Mar 31, 2025 | 24.32 Mn |
| Mar 31, 2025 | 24.32 Mn |
| Dec 31, 2024 | 28.64 Mn |
| Dec 31, 2024 | 28.64 Mn |
| Sep 30, 2024 | 22.58 Mn |
| Sep 30, 2024 | 22.58 Mn |
| Jun 30, 2024 | 22.55 Mn |
| Jun 30, 2024 | 22.55 Mn |
| Mar 31, 2024 | 20.26 Mn |
| Mar 31, 2024 | 20.26 Mn |